Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

NCT01972529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombocytopenia Associated With Liver Disease

Interventions

DRUG: avatrombopag (lower baseline platelet count)
DRUG: placebo (lower baseline platelet count)
DRUG: avatrombopag (higher baseline platelet count)
DRUG: placebo (higher baseline platelet count)

Sponsor

Eisai Inc.